Trial Profile
A Sequential Treatment Regimen of Cryotherapy and Picato for the Treatment of Actinic Keratosis on the Face and Scalp.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Sep 2016
Price :
$35
*
At a glance
- Drugs Ingenol mebutate (Primary)
- Indications Actinic keratosis; Skin cancer
- Focus Therapeutic Use
- Acronyms FIELD Study 1
- 21 Oct 2013 11 week results are expected to be published by the end of 2013, according to a LEO Pharma media release.
- 21 Oct 2013 Primary endpoint 'Objective-clinical-response-rate' has been met.
- 21 Oct 2013 Primary endpoint 'Complete-clinical-response-rate' has been met.